A Quintillion Reasons to Invest: SMCI and NVIDIA Propel Walmart and Global Industries to Trillions March 20, 2025 In the realm of investing, capital allocation reigns supreme—a disciplined endeavor to direct resources toward opportunities that maximize returns while minimizing systemic risk. In today’s data-driven global economy, Supermicro (SMCI) and NVIDIA...
Adobe has completed a 1st wave in a series of waves (3 up ), and then it has completed also a reactive, or is about to complete the reactive, and following time frames it indicates that April 11, 2025, we should start seeing the big bounce to exceed the $600 range. These moves are never a guarantee, however, I think that this prediction is quite plausible. Good...
CRISPR Therapeutics (CRSP) is the biotech rocket you’ve been waiting for—gene-editing’s crown jewel, ready to explode! With Casgevy, the world’s first FDA-approved CRISPR therapy (sickle cell + thalassemia), they’re not just promising—they’re delivering. Revenue’s incoming, and the pipeline’s stacked: blood disorders, cancer, diabetes—multi-billion-dollar markets...
NVIDIA’s crushing it as the undisputed king of AI chips, owning a jaw-dropping 70-95% market share. Their GPUs are the beating heart of data centers worldwide, powering the AI revolution with unstoppable momentum. Last four quarters? A cool $80B in revenue—growth that’s pure rocket fuel. Net margins at +56% scream profitability, while a forward P/E of 23.3...
SMCI SuperMicro Alert !!! sooo Urgent - don't miss it Greed rules the world, baby! FOMO for longs, pure terror for shorts—ALERT!!! Dump all metals NOW, pile into equities. High Beta or bust—High Tech only. Move FAST, minutes not hours, that’s my hot tip (wink wink). SMCI’s the play—not Tesla—oversold, over-shorted, tiny float, primed for a $20, $30, even $60 rip...
FREE - NO STRINGS ATTACHED - MARKET = SUPER OVERSOLD PRIMED FOR A MASSIVE SHORT SQUEEZE THE TRIGGER? LIQUIDITY FROM TARIFFS - THAT IS NEXT TRUMP PLANNED IT. AND HERE IT WILL COME On the technical side - yes, everyone sees this as voodoo magic - but it is a property of dynamic systems. What do you mean? Ahhhhh, measure and measure well from the previous move... it...
Imagine a company that’s not just riding the AI wave but steering it—Super Micro Computer (SMCI) is that titan. With demand for its servers skyrocketing—think $14.94 billion in 2024 revenue, doubled from the prior year, and a $40 billion 2026 target—it’s the undisputed king of high-performance computing. Why? SMCI’s mastered the art of execution, delivering...
I AM IMPLYING THAT THE MARKETS WILL RALLY VERY HARD. The Impact of Tariffs and Monetary Policy on VOO and the U.S. Economy The Vanguard S&P 500 ETF (VOO) has been experiencing significant growth, mirroring the strength of the U.S. economy and the shifting landscape of global finance16. This upward trajectory can be attributed to several interconnected factors,...
After weeks and weeks and weeks trying to find a button it looks like a Tesla found the bottom today. Take a look it looks promising. It looks like we could rebound to the low 400s at least and that is a good distance from here. Tesla remains a great company with increasing revenue from everywhere. You cannot sort it forever eventually reverse. I think Tesla has...
SMCI HAS MET ALL ITS THEORETICAL PIVOT POINTS. IN MY OPINION HUMBLE OPINION I THINK SUPERMICRO IS READY TO GO BACK UP. THE NEW THEORETICAL IS ABOVE $67. GOOD LUCK ENJOY THIS. STOCK HAS A VERY LOW PE. IT'S NOW CLEARED FROM ALL ACCUSATIONS THAT WERE MADE UP BY THE INFAMOUS HINDENBURG REPORT with the help of the woman from Ernst & Young who is a well-known...
Supermicro did excellently nice after hours, however, it also touched a particular pivot point so I think that tomorrow we should be able to find the CI at about 53 to 52 or 54 whatever it is a little lower because this was really a massive gap up and the market maker should not be so happy about this. They may need to bring everything down to be able to reengage...
the retracement meets all criteria, time to go long. If SmCi delivers on its projections of $40 Billion in revenue by 2026, that means that in 1 year the shares trade for $197 each. Super Micro Computer (SMCI) has recently experienced a significant pullback, retracing 20% from $67 to $50, which presents an attractive entry point for long positions. This...
Dear Readers, this is for fun as you know. Gentlemen and Ladies. The above represents a theoretical advance retracement - Prudent if you expect the 10k and 10k to be announced 2 - 27 - 2025
Yes this is an update, here is the fantastic company mired by shorts with an incredible line of therapies to churn trillions of dollars in revenue, with all the financing it needs to make this business become larger than and yof the pharma largest players including Pizer
Given the logical progression of infrastructure development, I anticipate an announcement from the current administration regarding the initiation of this project in the near future. The project's appeal lies in its incremental nature and relative ease of implementation. It can be initiated on a limited scale and expanded gradually, making it both cost-effective...
The stock is ready for a massive thrust UP to $129 or more.... Why is this. Well SMCI filed the 8K Report on December 2nd. There are rumores the 10k and 10q maybe ready. Lastly, business for SMCI is super strong. With Europe starting to negotiate large investments in AI, Sovereign AI, this means AI by country. Elon Musk has been speaking about AI data Centers...
The concept of "Sovereign AI" and SMCI building supercomputers in every country worldwide is an ambitious and speculative idea. Infrastructure Investment Building supercomputers in every country would require a massive global investment. Supercomputers are extremely expensive to design, build, and install, with costs ranging from $100 million to $300 million per...
EARNINGS ARE COMING AND THE WORD IS. THEY WILL SHOW REVENUE FOR THE 1ST TIME SINCE THEY STARTED. THIS STOCK IS 47% SHORTED. Did you know that just with the two therapies that have been approved, sickle cell disease and the other one related to cancer and T cells being overactive crisper therapeutics has an intrinsic value of $1075 per share. Just do the...